Literature DB >> 1374415

Requirement of the integrin beta 3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen.

D I Leavesley1, G D Ferguson, E A Wayner, D A Cheresh.   

Abstract

FG human pancreatic carcinoma cells use integrin alpha v beta 5 as their primary vitronectin receptor since they fail to express integrin alpha v beta 3. These cells are unable to form focal contacts, spread, or migrate on vitronectin but readily do so on collagen in a beta 1 integrin-dependent manner. Transfection of FG cells with a cDNA encoding the integrin beta 3 subunit results in the surface expression of a functional integrin alpha v beta 3 heterodimer providing these cells with novel adhesive and biological properties. Specifically, FG cells expressing beta 3 acquire the capacity to attach and spread on vitronectin as well as fibrinogen with beta 3 localization to focal contacts. Moreover, these cells gain the capacity to migrate through a porous membrane in response to either vitronectin or fibrinogen. These results demonstrate that the beta 3 and beta 5 integrin subunits when associated with alpha v, promote distinct cellular responses to a vitronectin extracellular environment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374415      PMCID: PMC2289489          DOI: 10.1083/jcb.117.5.1101

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  34 in total

Review 1.  New perspectives in cell adhesion: RGD and integrins.

Authors:  E Ruoslahti; M D Pierschbacher
Journal:  Science       Date:  1987-10-23       Impact factor: 47.728

Review 2.  Focal adhesions: transmembrane junctions between the extracellular matrix and the cytoskeleton.

Authors:  K Burridge; K Fath; T Kelly; G Nuckolls; C Turner
Journal:  Annu Rev Cell Biol       Date:  1988

Review 3.  Integrin, a transmembrane glycoprotein complex mediating cell-substratum adhesion.

Authors:  C A Buck; A F Horwitz
Journal:  J Cell Sci Suppl       Date:  1987

Review 4.  Integrins: a family of cell surface receptors.

Authors:  R O Hynes
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

5.  Platelet glycoprotein IIb-IIIa-like proteins mediate endothelial cell attachment to adhesive proteins and the extracellular matrix.

Authors:  I F Charo; L S Bekeart; D R Phillips
Journal:  J Biol Chem       Date:  1987-07-25       Impact factor: 5.157

6.  Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor.

Authors:  D A Cheresh; R C Spiro
Journal:  J Biol Chem       Date:  1987-12-25       Impact factor: 5.157

7.  Novel purification of vitronectin from human plasma by heparin affinity chromatography.

Authors:  T Yatohgo; M Izumi; H Kashiwagi; M Hayashi
Journal:  Cell Struct Funct       Date:  1988-08       Impact factor: 2.212

8.  Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin.

Authors:  J W Tamkun; D W DeSimone; D Fonda; R S Patel; C Buck; A F Horwitz; R O Hynes
Journal:  Cell       Date:  1986-07-18       Impact factor: 41.582

9.  Mechanism of fibronectin-mediated cell migration: dependence or independence of cell migration susceptibility on RGDS-directed receptor (integrin).

Authors:  A H Straus; W G Carter; E A Wayner; S Hakomori
Journal:  Exp Cell Res       Date:  1989-07       Impact factor: 3.905

10.  Complete amino acid sequence of a novel integrin beta subunit (beta 6) identified in epithelial cells using the polymerase chain reaction.

Authors:  D Sheppard; C Rozzo; L Starr; V Quaranta; D J Erle; R Pytela
Journal:  J Biol Chem       Date:  1990-07-15       Impact factor: 5.157

View more
  58 in total

1.  Cross talk between beta(1) and alpha(V) integrins: beta(1) affects beta(3) mRNA stability.

Authors:  S F Retta; G Cassarà; M D'Amato; R Alessandro; M Pellegrino; S Degani; G De Leo; L Silengo; G Tarone
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

2.  Integrin antagonist augments the therapeutic effect of adenovirus-mediated REIC/Dkk-3 gene therapy for malignant glioma.

Authors:  Y Shimazu; K Kurozumi; T Ichikawa; K Fujii; M Onishi; J Ishida; T Oka; M Watanabe; Y Nasu; H Kumon; I Date
Journal:  Gene Ther       Date:  2014-11-13       Impact factor: 5.250

Review 3.  The role of alphav integrins during angiogenesis.

Authors:  B P Eliceiri; D A Cheresh
Journal:  Mol Med       Date:  1998-12       Impact factor: 6.354

4.  Alphav integrins mediate adhesion and migration of breast carcinoma cell lines.

Authors:  N C Wong; B M Mueller; C F Barbas; P Ruminski; V Quaranta; E C Lin; J W Smith
Journal:  Clin Exp Metastasis       Date:  1998-01       Impact factor: 5.150

5.  Stepwise in vitro affinity maturation of Vitaxin, an alphav beta3-specific humanized mAb.

Authors:  H Wu; G Beuerlein; Y Nie; H Smith; B A Lee; M Hensler; W D Huse; J D Watkins
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

6.  Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF.

Authors:  M Schneller; K Vuori; E Ruoslahti
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

7.  Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells.

Authors:  S Klein; F G Giancotti; M Presta; S M Albelda; C A Buck; D B Rifkin
Journal:  Mol Biol Cell       Date:  1993-10       Impact factor: 4.138

8.  Granulocyte-macrophage and macrophage colony-stimulating factors differentially regulate alpha v integrin expression on cultured human macrophages.

Authors:  M O De Nichilo; G F Burns
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

9.  Multiple integrins mediate cell attachment to cytotactin/tenascin.

Authors:  A L Prieto; G M Edelman; K L Crossin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

10.  An integrin alpha(v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression.

Authors:  Jay S Desgrosellier; Leo A Barnes; David J Shields; Miller Huang; Steven K Lau; Nicolas Prévost; David Tarin; Sanford J Shattil; David A Cheresh
Journal:  Nat Med       Date:  2009-09-06       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.